{
  "schema_version": "2026-06-05",
  "purpose": "Machine-readable anchor text governance for TOGO internal links. Keeps priority products discoverable while preventing over-optimized anchors, unsafe claims, and duplicate intent routing.",
  "policy": {
    "research_use_only": true,
    "no_ranking_guarantees": true,
    "no_blackhat": true,
    "no_keyword_stuffing": true,
    "no_paid_link_schemes": true,
    "no_medical_claims": true,
    "no_dosing_guidance": true,
    "no_therapeutic_claims": true,
    "anchor_variety_required": true,
    "human_readability_first": true
  },
  "summary": {
    "anchor_routes_total": 18,
    "critical_routes": 12,
    "priority_product_targets": 12,
    "max_exact_anchor_share_percent": 25,
    "minimum_allowed_anchor_variants": 3
  },
  "anchor_routes": [
    {
      "id": "fatloss-category-to-retatrutide",
      "priority": "critical",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/category.html?cat=fat_loss",
      "target_page": "https://togopeptide.com/compound.html?slug=retatrutide",
      "target_type": "pdp",
      "priority_product_target": true,
      "target_slug": "retatrutide",
      "source_cluster_id": "retatrutide-research",
      "related_brief_id": "retatrutide-research-context-brief",
      "preferred_anchor_text": "Retatrutide research compound",
      "allowed_anchor_texts": [
        "Retatrutide research compound",
        "Retatrutide GLP-1 research profile",
        "triple-agonist research reference",
        "Retatrutide batch documentation"
      ],
      "anchor_mix": { "exact": 20, "partial": 35, "branded": 15, "descriptive": 30 },
      "placement": "Primary comparison row and relevant product-card support copy on the fat-loss category hub.",
      "rationale": "Connects high-intent category traffic to the highest-priority fat-loss PDP without letting broader category pages compete for the same exact product query.",
      "evidence_requirements": [
        "COA or batch-documentation link remains available near the PDP CTA.",
        "Category copy keeps commercial availability separate from research-context explanation."
      ],
      "safe_claim_boundaries": [
        "Anchor must frame the compound as research-use only.",
        "No wellness, treatment, or outcome promise may be attached to the link."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "fatloss-category-to-semaglutide",
      "priority": "critical",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/category.html?cat=fat_loss",
      "target_page": "https://togopeptide.com/compound.html?slug=semaglutide",
      "target_type": "pdp",
      "priority_product_target": true,
      "target_slug": "semaglutide",
      "source_cluster_id": "semaglutide-research",
      "related_brief_id": "semaglutide-research-context-brief",
      "preferred_anchor_text": "Semaglutide research profile",
      "allowed_anchor_texts": [
        "Semaglutide research profile",
        "Semaglutide GLP-1 lab listing",
        "semaglutide batch and COA page",
        "Semaglutide product documentation"
      ],
      "anchor_mix": { "exact": 20, "partial": 35, "branded": 15, "descriptive": 30 },
      "placement": "Fat-loss hub comparison table, stack context modules, and related research snippets.",
      "rationale": "Preserves Semaglutide PDP authority while category pages answer comparison intent.",
      "evidence_requirements": [
        "PDP must expose batch, image, and structured product data.",
        "Internal links must not imply personal-use outcomes."
      ],
      "safe_claim_boundaries": [
        "Research-use framing remains visible near the linked surface.",
        "Avoid practical use instructions in anchor-near copy."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "fatloss-category-to-tirzepatide",
      "priority": "critical",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/category.html?cat=fat_loss",
      "target_page": "https://togopeptide.com/compound.html?slug=tirzepatide",
      "target_type": "pdp",
      "priority_product_target": true,
      "target_slug": "tirzepatide",
      "source_cluster_id": "tirzepatide-research",
      "related_brief_id": "tirzepatide-research-context-brief",
      "preferred_anchor_text": "Tirzepatide research profile",
      "allowed_anchor_texts": [
        "Tirzepatide research profile",
        "Tirzepatide GIP and GLP-1 research",
        "tirzepatide product documentation",
        "Tirzepatide batch evidence"
      ],
      "anchor_mix": { "exact": 20, "partial": 35, "branded": 15, "descriptive": 30 },
      "placement": "Fat-loss category product-card support copy and GLP comparison modules.",
      "rationale": "Keeps dual-agonist research demand mapped to the PDP while comparison language stays on category/article surfaces.",
      "evidence_requirements": [
        "PDP product data and image data must resolve.",
        "Anchor-near copy keeps availability and research information separate."
      ],
      "safe_claim_boundaries": [
        "Research-only wording required.",
        "No promise of personal benefit or protocol result."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "fatloss-category-to-cagrilintide",
      "priority": "critical",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/category.html?cat=fat_loss",
      "target_page": "https://togopeptide.com/compound.html?slug=cagrilintide",
      "target_type": "pdp",
      "priority_product_target": true,
      "target_slug": "cagrilintide",
      "source_cluster_id": "cagrilintide-research",
      "related_brief_id": "cagrilintide-research-context-brief",
      "preferred_anchor_text": "Cagrilintide research profile",
      "allowed_anchor_texts": [
        "Cagrilintide research profile",
        "Cagrilintide lab listing",
        "amylin-analog research reference",
        "Cagrilintide batch documentation"
      ],
      "anchor_mix": { "exact": 20, "partial": 35, "branded": 15, "descriptive": 30 },
      "placement": "Fat-loss category top-pick module and related GLP comparison surfaces.",
      "rationale": "Gives the newer priority product a clear internal path from commercial category intent.",
      "evidence_requirements": [
        "PDP must expose canonical product slug and image.",
        "Evidence copy must point to batch and research framing, not outcome claims."
      ],
      "safe_claim_boundaries": [
        "Keep anchor language limited to research context.",
        "Do not connect the link to human-use instructions."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "glp-comparison-to-fatloss-category",
      "priority": "high",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/blog/glp-1-agonists-comparison.html",
      "target_page": "https://togopeptide.com/category.html?cat=fat_loss",
      "target_type": "category",
      "priority_product_target": false,
      "source_cluster_id": "category-hub-comparison",
      "related_brief_id": "fat-loss-category-comparison-brief",
      "preferred_anchor_text": "fat-loss research compounds hub",
      "allowed_anchor_texts": [
        "fat-loss research compounds hub",
        "GLP research category overview",
        "metabolic research category",
        "compare fat-loss research listings"
      ],
      "anchor_mix": { "exact": 10, "partial": 35, "branded": 15, "descriptive": 40 },
      "placement": "Article conclusion and contextual comparison summary.",
      "rationale": "Moves article readers toward the category hub while protecting PDPs from broad comparison intent.",
      "evidence_requirements": [
        "Article remains cited and research-framed.",
        "Category hub must include canonical self-reference and product-card links."
      ],
      "safe_claim_boundaries": [
        "Anchor must preserve research-category wording.",
        "Do not imply individual recommendations."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "skin-category-to-ghk-cu",
      "priority": "critical",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/category.html?cat=skin",
      "target_page": "https://togopeptide.com/compound.html?slug=ghk-cu",
      "target_type": "pdp",
      "priority_product_target": true,
      "target_slug": "ghk-cu",
      "source_cluster_id": "ghk-cu-skin-research",
      "related_brief_id": "ghk-cu-copper-research-brief",
      "preferred_anchor_text": "GHK-Cu copper-peptide research",
      "allowed_anchor_texts": [
        "GHK-Cu copper-peptide research",
        "GHK-Cu research profile",
        "copper-peptide lab listing",
        "GHK-Cu batch evidence"
      ],
      "anchor_mix": { "exact": 20, "partial": 35, "branded": 15, "descriptive": 30 },
      "placement": "Skin category top-pick card and glow-stack cross-link module.",
      "rationale": "Strengthens the main skin-category priority PDP with varied research anchors.",
      "evidence_requirements": [
        "PDP must retain research-use copy.",
        "COA or batch evidence should remain one click away."
      ],
      "safe_claim_boundaries": [
        "No skin-outcome promise near the link.",
        "Research context must be explicit."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "skin-category-to-klow-blend",
      "priority": "critical",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/category.html?cat=skin",
      "target_page": "https://togopeptide.com/compound.html?slug=klow-blend",
      "target_type": "pdp",
      "priority_product_target": true,
      "target_slug": "klow-blend",
      "source_cluster_id": "klow-blend-skin-research",
      "related_brief_id": "klow-blend-skin-research-brief",
      "preferred_anchor_text": "Klow Blend research profile",
      "allowed_anchor_texts": [
        "Klow Blend research profile",
        "Klow skin-matrix research listing",
        "Klow Blend batch evidence",
        "peptide blend research documentation"
      ],
      "anchor_mix": { "exact": 20, "partial": 35, "branded": 15, "descriptive": 30 },
      "placement": "Skin category featured card, glow stack module, and related product recommendations.",
      "rationale": "Explicitly routes high-priority Klow demand to the PDP instead of letting category copy absorb it.",
      "evidence_requirements": [
        "PDP slug and product feed entry must remain canonical.",
        "Anchor-near copy must separate blend composition from unsupported claims."
      ],
      "safe_claim_boundaries": [
        "Research-use framing required.",
        "No cosmetic result promise."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "glow-stack-to-snap-8",
      "priority": "critical",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/glow-stack.html",
      "target_page": "https://togopeptide.com/compound.html?slug=snap-8",
      "target_type": "pdp",
      "priority_product_target": true,
      "target_slug": "snap-8",
      "source_cluster_id": "snap-8-skin-research",
      "related_brief_id": "snap-8-skin-research-brief",
      "preferred_anchor_text": "SNAP-8 skin-matrix research",
      "allowed_anchor_texts": [
        "SNAP-8 skin-matrix research",
        "SNAP-8 research profile",
        "acetyl octapeptide lab listing",
        "SNAP-8 batch documentation"
      ],
      "anchor_mix": { "exact": 20, "partial": 35, "branded": 15, "descriptive": 30 },
      "placement": "Glow stack tier detail and related-products module.",
      "rationale": "Uses the stack page to reinforce the SNAP-8 PDP without turning the stack page into the primary product target.",
      "evidence_requirements": [
        "Stack page must retain component visibility.",
        "PDP must remain the canonical target for SNAP-8 product demand."
      ],
      "safe_claim_boundaries": [
        "Keep skin wording in research context.",
        "No personal-use or result-oriented claim."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "recovery-category-to-bpc-157",
      "priority": "critical",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/category.html?cat=recovery",
      "target_page": "https://togopeptide.com/compound.html?slug=bpc-157",
      "target_type": "pdp",
      "priority_product_target": true,
      "target_slug": "bpc-157",
      "source_cluster_id": "bpc-157-recovery-research",
      "related_brief_id": "bpc-157-recovery-context-brief",
      "preferred_anchor_text": "BPC-157 recovery research",
      "allowed_anchor_texts": [
        "BPC-157 recovery research",
        "BPC-157 research profile",
        "BPC-157 batch evidence",
        "recovery-category BPC-157 listing"
      ],
      "anchor_mix": { "exact": 20, "partial": 35, "branded": 15, "descriptive": 30 },
      "placement": "Recovery category top-pick card and recovery stack component text.",
      "rationale": "Protects the PDP as the primary target for exact BPC-157 demand.",
      "evidence_requirements": [
        "PDP and product feed pricing must remain aligned.",
        "Research copy must avoid outcome promises."
      ],
      "safe_claim_boundaries": [
        "Research-only wording required.",
        "No recovery-result or protocol claim."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "recovery-stack-to-tb-500",
      "priority": "critical",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/recovery-stack.html",
      "target_page": "https://togopeptide.com/compound.html?slug=tb-500",
      "target_type": "pdp",
      "priority_product_target": true,
      "target_slug": "tb-500",
      "source_cluster_id": "tb-500-recovery-research",
      "related_brief_id": "tb-500-recovery-context-brief",
      "preferred_anchor_text": "TB-500 recovery research",
      "allowed_anchor_texts": [
        "TB-500 recovery research",
        "TB-500 research profile",
        "thymosin beta-4 fragment listing",
        "TB-500 batch documentation"
      ],
      "anchor_mix": { "exact": 20, "partial": 35, "branded": 15, "descriptive": 30 },
      "placement": "Recovery stack component list and PDP cross-link modules.",
      "rationale": "Gives TB-500 a direct authority path from a relevant stack surface.",
      "evidence_requirements": [
        "Stack and PDP copy must remain consistent on component naming.",
        "Batch proof must remain discoverable from the PDP."
      ],
      "safe_claim_boundaries": [
        "Research context required.",
        "No human-use or outcome phrasing."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "longevity-category-to-nad-plus",
      "priority": "critical",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/category.html?cat=longevity",
      "target_page": "https://togopeptide.com/compound.html?slug=nad-plus",
      "target_type": "pdp",
      "priority_product_target": true,
      "target_slug": "nad-plus",
      "source_cluster_id": "nad-longevity-research",
      "related_brief_id": "nad-longevity-context-brief",
      "preferred_anchor_text": "NAD+ longevity research",
      "allowed_anchor_texts": [
        "NAD+ longevity research",
        "NAD+ research profile",
        "coenzyme research listing",
        "NAD+ batch documentation"
      ],
      "anchor_mix": { "exact": 20, "partial": 35, "branded": 15, "descriptive": 30 },
      "placement": "Longevity category product cards and related educational modules.",
      "rationale": "Keeps NAD+ exact demand aligned to the PDP while the category handles broader longevity comparison intent.",
      "evidence_requirements": [
        "PDP must expose canonical slug and product feed inclusion.",
        "Research-use boundary must stay visible."
      ],
      "safe_claim_boundaries": [
        "No anti-aging promise.",
        "Research framing required."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "longevity-stack-to-mots-c",
      "priority": "critical",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/longevity-stack.html",
      "target_page": "https://togopeptide.com/compound.html?slug=mots-c",
      "target_type": "pdp",
      "priority_product_target": true,
      "target_slug": "mots-c",
      "source_cluster_id": "mots-c-longevity-research",
      "related_brief_id": "mots-c-longevity-research-brief",
      "preferred_anchor_text": "MOTS-c longevity research",
      "allowed_anchor_texts": [
        "MOTS-c longevity research",
        "MOTS-c research profile",
        "mitochondrial peptide lab listing",
        "MOTS-c batch documentation"
      ],
      "anchor_mix": { "exact": 20, "partial": 35, "branded": 15, "descriptive": 30 },
      "placement": "Longevity stack component text and related product module.",
      "rationale": "Promotes the priority MOTS-c PDP from the most relevant bundle surface.",
      "evidence_requirements": [
        "Stack component naming must match PDP naming.",
        "PDP must remain canonical for exact product demand."
      ],
      "safe_claim_boundaries": [
        "Research-only language required.",
        "No longevity outcome claim."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "performance-stack-to-tesamorelin",
      "priority": "critical",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/performance-stack.html",
      "target_page": "https://togopeptide.com/compound.html?slug=tesamorelin",
      "target_type": "pdp",
      "priority_product_target": true,
      "target_slug": "tesamorelin",
      "source_cluster_id": "tesamorelin-research",
      "related_brief_id": "tesamorelin-research-context-brief",
      "preferred_anchor_text": "Tesamorelin research profile",
      "allowed_anchor_texts": [
        "Tesamorelin research profile",
        "Tesamorelin lab listing",
        "GHRH-analog research reference",
        "Tesamorelin batch evidence"
      ],
      "anchor_mix": { "exact": 20, "partial": 35, "branded": 15, "descriptive": 30 },
      "placement": "Performance stack component area and category support links.",
      "rationale": "Gives Tesamorelin a strong bundle-to-PDP path while keeping broader performance intent on stack/category pages.",
      "evidence_requirements": [
        "PDP remains canonical in product feed and visibility map.",
        "Anchor-near copy stays research-context only."
      ],
      "safe_claim_boundaries": [
        "No body-composition promise.",
        "Research-use framing required."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "coa-to-quality-proof",
      "priority": "high",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/coa.html",
      "target_page": "https://togopeptide.com/quality.html",
      "target_type": "evidence",
      "priority_product_target": false,
      "source_cluster_id": "certificate-of-analysis",
      "related_brief_id": "coa-hplc-ms-explainer",
      "preferred_anchor_text": "COA and batch documentation",
      "allowed_anchor_texts": [
        "COA and batch documentation",
        "quality evidence overview",
        "batch-verification process",
        "TogoPeptide quality proof"
      ],
      "anchor_mix": { "exact": 10, "partial": 35, "branded": 25, "descriptive": 30 },
      "placement": "COA explainer intro and footer support links.",
      "rationale": "Connects proof-seeking users and AI crawlers to the entity trust surface.",
      "evidence_requirements": [
        "Quality page must remain indexable.",
        "Evidence wording must remain specific and verifiable."
      ],
      "safe_claim_boundaries": [
        "Research quality context only.",
        "No purity guarantee beyond documented batch evidence."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "fresh-batch-to-shipping-policy",
      "priority": "high",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/fresh-batch.html",
      "target_page": "https://togopeptide.com/shipping.html",
      "target_type": "policy",
      "priority_product_target": false,
      "source_cluster_id": "fresh-batch-model",
      "related_brief_id": "fresh-batch-ordering-explainer",
      "preferred_anchor_text": "fresh-batch lead-time policy",
      "allowed_anchor_texts": [
        "fresh-batch lead-time policy",
        "shipping and batch timing",
        "fresh-batch fulfilment details",
        "delivery timing for research orders"
      ],
      "anchor_mix": { "exact": 10, "partial": 40, "branded": 10, "descriptive": 40 },
      "placement": "Fresh-batch explainer near order timing and policy references.",
      "rationale": "Prevents surprise around fresh-batch timing while giving policy pages stronger internal support.",
      "evidence_requirements": [
        "Shipping page must remain accessible from footer and policy links.",
        "Fresh-batch copy must not alter product pricing."
      ],
      "safe_claim_boundaries": [
        "Research-order logistics only.",
        "No fulfilment promise beyond published policy."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "reconstitution-guide-to-calculator",
      "priority": "high",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/reconstitution-guide.html",
      "target_page": "https://togopeptide.com/reconstitution-calculator.html",
      "target_type": "tool",
      "priority_product_target": false,
      "source_cluster_id": "reconstitution-calculator",
      "related_brief_id": "reconstitution-math-brief",
      "preferred_anchor_text": "reconstitution calculator",
      "allowed_anchor_texts": [
        "reconstitution calculator",
        "research preparation calculator",
        "concentration and volume calculator",
        "lab math calculator"
      ],
      "anchor_mix": { "exact": 15, "partial": 35, "branded": 10, "descriptive": 40 },
      "placement": "Guide intro, formula explanation, and tool CTA.",
      "rationale": "Routes calculation intent to the calculator page without crowding product PDPs.",
      "evidence_requirements": [
        "Calculator formulas must remain audited.",
        "Tool copy must clearly reject personal-use guidance."
      ],
      "safe_claim_boundaries": [
        "Research-lab math only.",
        "No personal protocol guidance."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "research-hub-to-research-use",
      "priority": "high",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/research-hub.html",
      "target_page": "https://togopeptide.com/research-use.html",
      "target_type": "policy",
      "priority_product_target": false,
      "source_cluster_id": "research-use-policy",
      "related_brief_id": "research-use-policy-explainer-brief",
      "preferred_anchor_text": "research-use policy",
      "allowed_anchor_texts": [
        "research-use policy",
        "laboratory-use boundary",
        "research-only ordering policy",
        "TogoPeptide research-use terms"
      ],
      "anchor_mix": { "exact": 15, "partial": 35, "branded": 20, "descriptive": 30 },
      "placement": "Research hub intro and compliance support sections.",
      "rationale": "Makes the compliance boundary easy for crawlers and users to resolve.",
      "evidence_requirements": [
        "Policy page must remain linked from footer.",
        "Research hub must keep policy wording visible."
      ],
      "safe_claim_boundaries": [
        "Research-only scope required.",
        "No medical or personal-use wording."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    },
    {
      "id": "stack-builder-to-stacks-hub",
      "priority": "high",
      "status": "anchor_ready",
      "source_page": "https://togopeptide.com/stack-builder.html",
      "target_page": "https://togopeptide.com/stacks.html",
      "target_type": "stack",
      "priority_product_target": false,
      "source_cluster_id": "stack-builder-research",
      "related_brief_id": "stack-builder-methodology-brief",
      "preferred_anchor_text": "research stack overview",
      "allowed_anchor_texts": [
        "research stack overview",
        "compare research stacks",
        "TogoPeptide stack hub",
        "bundle research categories"
      ],
      "anchor_mix": { "exact": 10, "partial": 35, "branded": 25, "descriptive": 30 },
      "placement": "Stack-builder result summary and empty-state guidance.",
      "rationale": "Links tool users to the canonical stack hub while keeping individual stack pages focused.",
      "evidence_requirements": [
        "Stack hub cards must remain visible and image-backed.",
        "Tool-to-hub copy must not imply recommendations."
      ],
      "safe_claim_boundaries": [
        "Research-comparison context only.",
        "No recommendation or outcome promise."
      ],
      "verification_commands": ["npm run qa:anchor-equity", "npm run qa:link-equity"]
    }
  ]
}
